Telix Pharmaceuticals Financials

Values in thousands	2026-06-30	2025-12-31	2025-06-30	2024-12-31
Revenue	$476,037	$410,036	$355,137	$594,244
Gross Profit	245,554	216,387	172,650	385,797
EBITDA	11,909	19,115	8,532	82,781
EBIT	-13,708	7,292	-1,055	78,461
Net Income	38,224	-4,793	-2,085	38,239
Net Change In Cash	476,037	410,036	355,137	594,244
Free Cash Flow	4,059	-61,196	10,081	-5,684
Cash	251,815	141,820	208,240	710,346
Basic Shares	356,890	338,778	337,202	345,188

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$789,771	$783,207	$502,547	$160,096
Gross Profit	419,466	509,678	314,390	94,926
EBITDA	52,304	100,573	22,966	-92,837
EBIT	30,902	92,547	16,223	-98,216
Net Income	-7,000	49,919	5,211	-104,079
Net Change In Cash	789,771	783,207	502,547	160,096
Free Cash Flow	-54,245	28,707	14,205	-71,008
Cash	141,820	710,346	123,237	116,329
Basic Shares	337,880	345,188	323,710	310,644